VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 140 filers reported holding VIKING THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $298,115 | -31.3% | 26,930 | +3.3% | 0.00% | -50.0% |
Q1 2023 | $433,949 | +1012.7% | 26,063 | +81.2% | 0.00% | – |
Q3 2022 | $39,000 | -9.3% | 14,382 | -2.6% | 0.00% | – |
Q2 2022 | $43,000 | -20.4% | 14,763 | -17.2% | 0.00% | – |
Q1 2022 | $54,000 | -82.7% | 17,840 | -73.8% | 0.00% | -100.0% |
Q4 2021 | $313,000 | +63.9% | 68,119 | +124.0% | 0.00% | 0.0% |
Q3 2021 | $191,000 | -67.8% | 30,415 | -69.3% | 0.00% | -50.0% |
Q2 2021 | $594,000 | -11.6% | 99,166 | -6.7% | 0.00% | -50.0% |
Q1 2021 | $672,000 | +168.8% | 106,255 | +139.6% | 0.00% | +100.0% |
Q4 2020 | $250,000 | -56.9% | 44,348 | -55.5% | 0.00% | -75.0% |
Q3 2020 | $580,000 | -34.5% | 99,684 | -9.7% | 0.01% | +60.0% |
Q4 2019 | $885,000 | +59.7% | 110,347 | +37.1% | 0.01% | 0.0% |
Q3 2019 | $554,000 | -50.8% | 80,479 | -40.7% | 0.01% | -54.5% |
Q2 2019 | $1,126,000 | +123.9% | 135,718 | +168.2% | 0.01% | +120.0% |
Q1 2019 | $503,000 | -13.4% | 50,600 | -33.4% | 0.01% | -28.6% |
Q4 2018 | $581,000 | – | 75,943 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 250,000 | $2,005,000 | 5.90% |
Sio Capital Management, LLC | 731,453 | $5,866,000 | 1.40% |
KNOTT DAVID M | 218,102 | $1,749,000 | 0.71% |
ArrowMark Colorado Holdings LLC | 8,813,578 | $70,685,000 | 0.63% |
DAFNA Capital Management LLC | 209,200 | $1,678,000 | 0.58% |
Park West Asset Management LLC | 1,545,075 | $12,391,000 | 0.52% |
SPHERA FUNDS MANAGEMENT LTD. | 590,000 | $4,732,000 | 0.39% |
Cornerstone Capital, Inc. | 245,796 | $1,971,000 | 0.28% |
Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |
Ikarian Capital, LLC | 150,000 | $1,203,000 | 0.20% |